Entry |
|
Name |
Fisogatinib (USAN/INN) |
Formula |
C24H24Cl2N4O4
|
Exact mass |
502.1175
|
Mol weight |
503.37
|
Structure |
|
Class |
Antineoplastic
DG01918 Tyrosine kinase inhibitor
DG01917 Receptor tyrosine kinase inhibitor
|
Efficacy |
Antineoplastic, Receptor tyrosine kinase inhibitor |
Target |
|
Pathway |
|
Interaction |
|
Brite |
Drug groups [BR:br08330]
Antineoplastic
DG01918 Tyrosine kinase inhibitor
DG01917 Receptor tyrosine kinase inhibitor
D11737 Fisogatinib
Target-based classification of drugs [BR:br08310]
Protein kinases
Receptor tyrosine kinases (RTK)
FGFR family
FGFR4
D11737 Fisogatinib (USAN/INN)
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 34
1 C8y C 21.6949 -15.4468
2 C8y C 21.6949 -16.8515
3 C8y C 22.8889 -17.5539
4 C8y C 24.1531 -16.8515
5 C8x C 24.1531 -15.4468
6 C8y C 22.8889 -14.7444
7 O2a O 22.8889 -13.3397
8 C1a C 21.6949 -12.6374
9 O2a O 25.3471 -17.5539
10 C1a C 26.5411 -16.8515
11 X Cl 22.8889 -18.9586
12 X Cl 20.5009 -14.7444
13 C8y C 20.5009 -17.5539
14 C8x C 19.3069 -16.8515
15 C8y C 18.0427 -17.5539
16 C8y C 18.0427 -18.9586
17 C8x C 19.2367 -19.6609
18 C8x C 20.5009 -18.9586
19 C8x C 16.8487 -16.8515
20 N5x N 15.6547 -17.5539
21 C8y C 15.6547 -18.9586
22 N5x N 16.8487 -19.6609
23 N1b N 14.4607 -19.6609
24 C1y C 13.2667 -18.9586
25 C1y C 13.2667 -17.5539
26 C1x C 12.0025 -16.8515
27 C1x C 10.8085 -17.5539
28 O2x O 10.8085 -18.9586
29 C1x C 12.0025 -19.6609
30 N1b N 14.4607 -16.8515
31 C5a C 14.4607 -15.4468
32 O5a O 15.6547 -14.7444
33 C2b C 13.2667 -14.7444
34 C2a C 12.0635 -15.4266
BOND 37
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 6 7 1
8 7 8 1
9 4 9 1
10 9 10 1
11 3 11 1
12 1 12 1
13 2 13 1
14 13 14 2
15 14 15 1
16 15 16 2
17 16 17 1
18 17 18 2
19 13 18 1
20 15 19 1
21 19 20 2
22 20 21 1
23 21 22 2
24 16 22 1
25 21 23 1
26 24 23 1 #Down
27 24 25 1
28 25 26 1
29 26 27 1
30 27 28 1
31 28 29 1
32 24 29 1
33 25 30 1 #Down
34 30 31 1
35 31 32 2
36 31 33 1
37 33 34 2
|